IL13RA2 and central nervous system cancer: Interestingly, one of these studies showed a higher expression of IL13Rα2 on stem-like vs. differentiated glioma populations, indicating that IL13Rα2-directed immunotherapeutic approaches could be useful for eradicating therapeutically resistant glioblastoma stem cell (GSC) populations (62).